Publikationen mit Produkten von Varimol

7. Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler; Pharmaceutics 2022, 14, 2114.

Toward Optimized 89Zr‐Immuno‐PET: Side‐by‐Side Comparison of [89Zr]Zr‐DFO‐, [89Zr]Zr‐3,4,3‐(LI‐1,2‐HOPO)‐ and [89Zr]Zr‐DFO*‐Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable? DOI.

6. Wolfgang Kaim*, Isabell Löw, Mark R. Ringenberg, Brigitte Schwederski, Vasileios Filippou, Jan Fiedler; Z. Anorg. Allg. Chem. 2022.

Tetrazine Chelate Ligands Bridging Two [Ru(acac)2] Fragments: Mixed Valency and Radical Complex Formation, DOI.

5. Marc Schnierle, Mario Winkler, Vasileios Filippou, Joris van Slageren*, Mark R. Ringenberg*; Eur. J. Inorg. Chem. 2022.

(Spectro)Electrochemistry of 3-(Pyrid-2-yl)-s-Tetrazine- and 1,2-(Dihydro)pyridazine Tricarbonylrhenium(I)chloride, DOI.

4. Helen Damerow, Ralph Hübner, Benedikt Judmann, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler*; Cancers 2021, 13, 6349.

Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability, DOI.

3. Aneta Turlik, K. N. Houk, Dennis Svatunek*; J. Org. Chem. 2021, 86, 13129-13133.

Origin of Increased Reactivity in Rhenium-Mediated Cycloadditions of Tetrazines, DOI.

2. Marc Schnierle, Marie Leimkühler, Mark R. Ringenberg*; Inrog. Chem. 2021, 60, 6367-6374

[(η6 -p-Cymene)[3-(pyrid-2-yl)-1,2,4,5-tetrazine]chlororuthenium(II)]+ , Redox Noninnocence and Dienophile Addition to Coordinated Tetrazine, DOI.

1. Marc Schnierle, Svenja Blickle, Vasileios Filippou*, Mark R. Ringenberg*; Chem. Commun. 2020, 56, 12033-12036. 

Tetrazine metallation boosts rate and regioselectivity of inverse electron demand Diels–Alder (iEDDA) addition of dienophiles, DOI.

 

Warenkorb
WordPress Cookie Plugin by Real Cookie Banner